Education
Single Daily HIV Pill Shows Promising Phase 3 Trial Results From UK Research
A Queen Mary University-led trial found a new combined bictegravir-lenacapavir tablet could replace complex multi-drug regimens for HIV patients
Latest reporting, analysis and explainers from National Herald UK.
A Queen Mary University-led trial found a new combined bictegravir-lenacapavir tablet could replace complex multi-drug regimens for HIV patients